Clinical Trial Update: Impact of Parathyroid Hormone (PTH) on Osseous Cavity [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the impact of Parathyroid Hormone (PTH) on osseous cavities in bone loss and periodontitis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Loss
• Periodontitis

Drugs mentioned

• Parathyroid hormone (Parathyroid hormone)

Snippet

Sponsor: University of Michigan | Conditions: Bone Loss, Periodontitis | Phase 1 | Status: COMPLETED